Prognostic potential of immune inflammatory biomarkersin breast cancer patients treated withneoadjuvant chemotherapy

HIGHLIGHTS

• who: Marta Truffi et al. from the Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy have published the paper: Prognostic Potential of Immune Inflammatory Biomarkersin Breast Cancer Patients Treated withNeoadjuvant Chemotherapy, in the Journal: Cancers 2022, 14, 5287. of /2022/
• what: The authors aimed to investigate the role of these biomarkers in predicting distant relapse in breast cancer patients treated with (NACT). The study showed that the MLR was a significant independent parameter affecting DMFS in breast cancer patients undergoing NACT.
• how: The clinical-pathological features of the lesions included in the study are . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.